Discovery and Development at Boehringer Ingelheim Pharmaceuticals, Inc. focuses on cardiovascular and immunology/inflammatory diseases. The Cardiovascular Disease department utilizes multidisciplinary research technologies to develop new treatments for heart failure, hypertension and atherosclerosis. The Immunology and Inflammation department investigates human systems to uncover mechanisms responsible for Rheumatoid Arthritis (RA), Multiple Sclerosis (MS), and Psoriasis.

 

 

 

© 2009-2010 Boehringer Ingelheim Corporation or an affiliated company. All rights reserved. Use of this site is subject to the terms and conditions set out in the Agreement to use the Boehringer Ingelheim Corporation and its U.S. affiliates' web sites. All content intended for U.S. residents only. Terms of Use and Privacy Policy.